The outcome of patients with serous papillary peritoneal cancer, fallopian tube cancer, and epithelial ovarian cancer by treatment eras: 27 years data from the SEER registry

Bevacizumab (Avastin®) in cancer treatment: A review of 15 years of clinical experience and future outlook

(2020) Josep Garcia et al.   CANCER TREATMENT REVIEWS

Development of new poly(ADP-ribose) polymerase (PARP) inhibitors in ovarian cancer: Quo Vadis?

(2020) Stergios Boussios et al.   Annals of Translational Medicine

ESMO–ESGO consensus conference recommendations on ovarian cancer: pathology and molecular biology, early and advanced stages, borderline tumours and recurrent disease†

(2019) N Colombo et al.   ANNALS OF ONCOLOGY

Serous ovarian, fallopian tube and primary peritoneal cancers: A common disease or separate entities — A systematic review

(2015) Rie D. Sørensen et al.   GYNECOLOGIC ONCOLOGY

The new FIGO staging system for ovarian, fallopian tube, and primary peritoneal cancer

(2014) F. Zeppernick et al.   ARCHIVES OF GYNECOLOGY AND OBSTETRICS

Staging classification for cancer of the ovary, fallopian tube, and peritoneum

(2013) Jaime Prat et al.   INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS

Cancer of unknown primary site

(2012) Nicholas Pavlidis et al.   LANCET

TP53 mutations in serous tubal intraepithelial carcinoma and concurrent pelvic high-grade serous carcinoma-evidence supporting the clonal relationship of the two lesions

(2011) Elisabetta Kuhn et al.   JOURNAL OF PATHOLOGY

Ovarian Low-grade and High-grade Serous Carcinoma

(2009) Russell Vang et al.   ADVANCES IN ANATOMIC PATHOLOGY

Defining the Cut Point Between Low-grade and High-grade Ovarian Serous Carcinomas

(2009) Ayse Ayhan et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

Serous papillary peritoneal carcinoma: Unknown primary tumour, ovarian cancer counterpart or a distinct entity? A systematic review

(2009) George Pentheroudakis et al.   CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY